Journal of Endocrinological Investigation

, Volume 33, Issue 10, pp 691–695 | Cite as

Effects of growth hormone on body proportions in Turner syndrome compared with non-treated patients and normal women

  • A. D. Baldin
  • T. Fabbri
  • A. A. Siviero-Miachon
  • A. M. Spinola-Castro
  • S. H. V. Lemos-Marini
  • M. T. M. Baptista
  • L. F. R. D’Souza-Li
  • A. T. Maciel-Guerra
  • G. Guerra-Junior
Original Articles


Background: The majority of anthropometric assessments in Turner syndrome (TS) patients has focused on height. AIM: To analyze body proportions in young adult TS patients either treated or not treated with rhGH, and to compare them with a group of age-matched healthy women. Subjects and methods: Standing height, sitting height, weight, foot and leg lengths, arm span, head circumference, biliac and biacromial diameters were measured in 52 non-treated TS patients, 30 treated with rhGH and 133 healthy women. Results: Age at the start of rhGH therapy varied from 7.8 to 15.1 yr (10.0±1.3 yr), the duration of treatment from 2.8 to 8.2 yr (3.7±1.5 yr) and the mean recombinant human GH (rhGH) dose was 0.42 mg/kg/week (from 0.32 to 0.50 mg/kg/week). Non-treated patients did not show any difference in anthropometric variables when compared with the treated ones, except for hand length (p=0.02) and height (p=0.05), which were increased in the treated group. All anthropometric variables, except head circumference, were different when comparing TS patients (either treated or not) with age-matched healthy women. Conclusion: Brazilian TS patients either treated or not with rhGH showed almost no differences in terms of their body proportions. This result is probably due to the late age at the start of treatment, and/or the short period of rhGH administration. Hand length was different between the groups, showing the importance of including the extremities in body proportion assessment during rhGH treatment of TS patients.


Turner syndrome growth hormone body proportions height weight 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ranke MB, Saenger P. Turner’s syndrome. Lancet 2001, 358: 309–14.PubMedCrossRefGoogle Scholar
  2. 2.
    Ranke MB. Growth in Turner’s syndrome. Acta Paediatr 1994, 83: 343–4.PubMedCrossRefGoogle Scholar
  3. 3.
    Rao E, Weiss B, Fukami M, et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 1997, 16: 54–63.PubMedCrossRefGoogle Scholar
  4. 4.
    Ranke MB, Grauer ML. Adult height in Turner syndrome: results of multinational survey 1993. Horm Res 1994, 42: 90–4.PubMedCrossRefGoogle Scholar
  5. 5.
    Lemos-Marini SHV, Morcillo AM, Baptista MTM, Guerra-Junior G, Maciel-Guerra AT. Spontaneous final height in Turner’s syndrome in Brazil. J Pediatr Endocrinol Metab 2007, 20: 1207–14.PubMedCrossRefGoogle Scholar
  6. 6.
    Baxter L, Bryant J, Cave CB, Milne R. Recombinant growth hormone for children and adolescents with Turner syndrome. Cochrane Database Syst Rev 2007, 24: CDC003887.Google Scholar
  7. 7.
    van Teunenbroek A, de Muinck Keizer-Schrama SM, Stijnen T, et al. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone. J Clin Endocrinol Metab 1996, 81: 4013–21.PubMedGoogle Scholar
  8. 8.
    Carel JC, Mathivon L, Gendrel C, Ducret JP, Chaussain JL. Near normalization of final height with adapted doses of growth hormone in Turner’s syndrome. J Clin Endocrinol Metab 1998, 83: 1462–6.PubMedGoogle Scholar
  9. 9.
    Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, et al. Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial. J Clin Endocrinol Metab 1999, 84: 4607–12.PubMedGoogle Scholar
  10. 10.
    Reiter EO, Blethen SL, Baptista J, Price L. Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner’s syndrome. J Clin Endocrinol Metab 2001, 86: 1936–41.PubMedGoogle Scholar
  11. 11.
    Quigley CA, Crowe BJ, Anglin DG, Chipman JJ. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height. J Clin Endocrinol Metab 2002, 87: 2033–41.PubMedCrossRefGoogle Scholar
  12. 12.
    Ranke MB, Partsch CJ, Lindberg A, et al. Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-up Study 2001. Eur J Endocrinol 2002, 147: 625–33.PubMedCrossRefGoogle Scholar
  13. 13.
    van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, et al. Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab 2003, 88: 1119–25.PubMedCrossRefGoogle Scholar
  14. 14.
    Wasniewska M, De Luca F, Bergamaschi R, et al. Early treatment with GH alone in Turner syndrome: prepubertal catch-up growth and waning effect. Eur J Endocrinol 2004, 151: 567–72.PubMedCrossRefGoogle Scholar
  15. 15.
    Stephure DK; Canadian Growth Hormone Advisory Committee. Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian randomized controlled trial. J Clin Endocrinol Metab 2005, 90: 3360–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Pasquino AM, Pucarelli I, Segni M, Tarani L, Calcaterra V, Larizza D. Adult height in sixty girls with Turner syndrome treated with growth hormone matched with an untreated group. J Endocrinol Invest 2005; 28: 350–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Soriano-Guillen L, Coste J, Ecosse E, et al. Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone. J Clin Endocrinol Metab 2005, 90: 5197–204.PubMedCrossRefGoogle Scholar
  18. 18.
    Ranke MB, Lindberg A, Ferrández Longás A, et al. Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS. Pediatr Res 2007, 61: 105–10.PubMedCrossRefGoogle Scholar
  19. 19.
    Davenport ML, Crowe BJ, Travers SH, et al. Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial. J Clin Endocrinol Metab 2007, 92: 3406–16.PubMedCrossRefGoogle Scholar
  20. 20.
    Khatchadourian K, Huot C, Alos N, Van Vliet G, Deal C. Impact of patient characteristics and clinical factors on the decision to initiate growth hormone treatment in Turner syndrome. Horm Res 2008, 70: 300–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Davenport ML. Moving toward an understanding of hormone replacement therapy in adolescent girls: looking through the lens of Turner syndrome. Ann NY Acad Sci 2008, 1135: 126–37.PubMedCrossRefGoogle Scholar
  22. 22.
    Hjerrild BE, Mortensen KH, Gravholt CH. Turner syndrome and clinical treatment. Br Med Bull 2008, 86: 77–93.PubMedCrossRefGoogle Scholar
  23. 23.
    Zellner K, Keller E, Kromeyer K, Jaeger U. Acromegaloidal changes in Ulrich-Turner syndrome after treatment with growth hormone. Acta Med Auxol 1997, 29: 125–33.Google Scholar
  24. 24.
    Sas TC, Gerver WJ, de Bruin R, et al. Body proportions during long-term growth hormone treatment in girls with Turner syndrome participating in a randomized dose-response trial. J Clin Endocrinol Metab 1999, 84: 4622–8.PubMedGoogle Scholar
  25. 25.
    Schweizer R, Ranke MB, Binder G, et al. Experience with growth hormone therapy in Turner syndrome in a single centre: low total height gain, no further gains after puberty onset and unchanged body proportions. Horm Res 2000, 53: 228–38.PubMedCrossRefGoogle Scholar
  26. 26.
    Hughes PC, Ribeiro J, Hughes IA. Body proportions in Turner’s syndrome. Arch Dis Child 1986, 61: 506–7.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Rongen-Westerlaken C, Rikken B, Vastrick P, et al. Body proportions in individuals with Turner syndrome. The Dutch Growth Hormone Working Group. Eur J Pediatr 1993, 152: 813–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Gravholt CH, Naeraa RW. Reference values for body proportions and body composition in adult women with Ullrich-Turner syndrome. Am J Med Genet 1997, 72: 403–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Baldin AD, Armani MC, Morcillo AM, et al. Body proportions in a group of Brazilian patients with Turner syndrome. Arq Bras Endocrinol Metab 2005, 49: 529–35.CrossRefGoogle Scholar
  30. 30.
    Hall JG, Froster-Iskenius UG, Allanson JE. A handbook of normal physical measurements. Oxford: Oxford Medical Publications. 1989, 1–504.Google Scholar
  31. 31.
    Gerver WJM, Bruin R. Pediatric morphometrics. A reference manual. Maastricht: Universitaire Pers Maastricht. 2001, 1–322.Google Scholar
  32. 32.
    Varela J, Vinkka H, Alvesalo L. The phenotype of 45,X females: an anthropometric quantification. Ann Hum Biol 1984, 11: 53–66.CrossRefGoogle Scholar
  33. 33.
    Neufeld ND, Lippe BM, Kaplan SA. Disproportionate growth of the lower extremities. A major determinant of short stature in Turner’s syndrome. Am J Dis Child 1978, 132: 296–8.PubMedCrossRefGoogle Scholar
  34. 34.
    Ikeda Y, Higurashi M, Egi S, Ohzeki N, Hoshina H. An anthropometric study of girls with Ulrich-Turner syndrome. Am J Med Genet 1982, 12: 271–80.PubMedCrossRefGoogle Scholar
  35. 35.
    Marcondes E. Development of child. Biologic development and growth. Rio de Janeiro: Brazilian Pediatric Society. 1994, 1–75. [Portuguese]Google Scholar
  36. 36.
    Seaver LH, Irons M, American College of Medical Genetics (ACMG) Professional Practice and Guidelines Committee. ACMG practice guideline: genetic evaluation of short stature. Genet Med 2009, 11: 465–70.PubMedCentralPubMedCrossRefGoogle Scholar
  37. 37.
    Hokken-Koelega A, van Pareren Y, Arends N. Effects of growth hormone treatment on cognitive function and head circumference in children born small for gestational age. Horm Res 2005, 64 (Suppl 3): 95–9.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2010

Authors and Affiliations

  • A. D. Baldin
    • 1
  • T. Fabbri
    • 2
  • A. A. Siviero-Miachon
    • 2
  • A. M. Spinola-Castro
    • 2
  • S. H. V. Lemos-Marini
    • 1
  • M. T. M. Baptista
    • 1
  • L. F. R. D’Souza-Li
    • 1
  • A. T. Maciel-Guerra
    • 1
  • G. Guerra-Junior
    • 1
  1. 1.Paediatric Endocrinology, Department of Paediatrics, Faculty of Medical SciencesUniversity of Campinas, (UNICAMP)CampinasBrazil
  2. 2.Paediatric Endocrinology, Department of PaediatricsFederal University of Sao Paulo (UNIFESP/EPM)Sao PauloBrazil

Personalised recommendations